S&P 500
(-0.27%) 4 288.05 points
Dow J
(-0.47%) 33 508 points
Nasdaq
(0.14%) 13 219 points
Oil
(-1.02%) $90.77
Gas
(-0.51%) $2.93
Gold
(-0.75%) $1 864.60
Silver
(-1.54%) $22.39
Platinum
(-0.01%) 915.00
USD/EUR
(-0.07%) 0.946
USD/NOK
(-0.40%) 10.68
USD/GBP
(0.07%) 0.820
USD/RUB
(-0.60%) 96.05

Realtime updates for Yuhan Corporation [000105.KS]

Exchange: KSC Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated27 Sep 2023 @ 02:30

1.27% KRW 64 000

Live Chart Being Loaded With Signals

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...

Stats
Today's Volume 5 292.00
Average Volume 3 237.00
Market Cap 5 325.70B
P/E 0
ATR14 KRW213.55 (0.33%)

Volume Correlation

Long: 0.41 (neutral)
Short: -0.93 (very strong negative)
Signal:(31.091) Neutral

Yuhan Corporation Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuhan Corporation Correlation - Currency/Commodity

The country flag -0.30
( neutral )
The country flag -0.44
( neutral )
The country flag -0.19
( neutral )
The country flag -0.21
( neutral )
The country flag 0.57
( weak )
The country flag -0.13
( neutral )

Yuhan Corporation Financials

Annual 2022
Revenue: KRW1 775.85B
Gross Profit: KRW518.20B (29.18 %)
EPS: KRW1 329.00
Q2 2023
Revenue: KRW495.72B
Gross Profit: KRW152.82B (30.83 %)
EPS: KRW121.53
Q1 2023
Revenue: KRW443.05B
Gross Profit: KRW135.56B (30.60 %)
EPS: KRW311.00
Q4 2022
Revenue: KRW450.50B
Gross Profit: KRW136.17B (30.23 %)
EPS: KRW533.71

Yuhan Corporation

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; and Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury. The company also provides ETC products, such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems, as well as anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. In addition, it offers over-the-counter (OTC) products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. Further, the company engages in dental business and provides implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and companion animals; and provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

Estimated
000105.KS Next Dividend
(Unknown) KRW0 Probabilty 0 %
Quarter Ratio
000105.KS 0.00 0.00
Pay Frequency
000105.KS Insufficient data to determine frequency 0
Yearly Payout
000105.KS

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

DISCLAIMER:

"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 5.9543390274048 seconds
Number of API calls: 1
Number of DB calls: 9